Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:878164.
doi: 10.1155/2015/878164. Epub 2015 Dec 27.

Huangqi Jianzhong Tang for Treatment of Chronic Gastritis: A Systematic Review of Randomized Clinical Trials

Affiliations
Review

Huangqi Jianzhong Tang for Treatment of Chronic Gastritis: A Systematic Review of Randomized Clinical Trials

Yue Wei et al. Evid Based Complement Alternat Med. 2015.

Abstract

To assess the clinical effects and safety of Huangqi Jianzhong Tang (HQJZ) for the treatment of chronic gastritis (CG), three English databases and four Chinese databases were searched through the inception to January 2015. In randomized controlled trials (RCTs) comparing HQJZ with placebo, no intervention and western medicine were included. A total of 9 RCTs involving 979 participants were identified. The methodological quality of the included trials was generally poor. Meta-analyses demonstrated that HQJZ plus conventional medicine was more effective in improving overall gastroscopy outcome than western medicine alone for treatment of chronic superficial gastritis with the pooling result of overall improvement [OR 3.78 (1.29,11.06), P = 0.02]. In addition, the combination of HQJZ with antibiotics has higher overall effect rate than antibiotics alone for the treatment of CG [OR 2.60 (1.49,4.54), P = 0.0007]. There were no serious adverse events reported in both the intervention and controlled groups. HQJZ has the potential of improvement of the patients' gastroscopy outcomes, Helicobacter pylori clearance rate, traditional Chinese Medicine syndromes, and overall effect rate alone or in combination use with conventional western medicine for chronic atrophic gastritis. However, due to poor methodological quality, the beneficial effect and safeties of HQJZ for CG could not be confirmed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of literature search.
Figure 2
Figure 2
Forest plot of improvement of overall effect rate for patients with CAG.
Figure 3
Figure 3
Forest plot of improvement of overall effect rate for patients with CSG.
Figure 4
Figure 4
Forest plot of improvement of overall effect rate for patients with CG.

Similar articles

Cited by

References

    1. Fang J.-Y., Liu W.-Z., Li Z.-S., et al. Chinese consensus on chronic gastritis. Chinese Journal of Gastroenterology. 2013;33(1):5–16.
    1. Rugge M., Meggio A., Pennelli G., et al. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007;56(5):631–636. doi: 10.1136/gut.2006.106666. - DOI - PMC - PubMed
    1. Varbanova M., Frauenschläger K., Malfertheiner P. Chronic gastritis—an update. Best Practice & Research Clinical Gastroenterology. 2014;28(6):1031–1042. doi: 10.1016/j.bpg.2014.10.005. - DOI - PubMed
    1. Leal-Herrera Y., Torres J., Monath T. P., et al. High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection. The American Journal of Gastroenterology. 2003;98(11):2395–2402. doi: 10.1111/j.1572-0241.2003.07708.x. - DOI - PubMed
    1. Zendehdel N., Nasseri-Moghaddam S., Malekzadeh R., Massarrat S., Sotoudeh M., Siavoshi F. Helicobacter pylori reinfection rate 3 years after successful eradication. Journal of Gastroenterology and Hepatology. 2005;20(3):401–404. doi: 10.1111/j.1440-1746.2005.03561.x. - DOI - PubMed